Drug pricing regulator fixes maximum retail cost for Sun Pharma pain relief gel

The drug pricing regulator has fixed a retail cost of Rs 6.25 per gram for the pharmaceutical pain relief gel manufactured by Sun Pharma. This price cap applies specifically to the formulation distributed by this entity under the oversight of the regulatory body. Companies must ensure that retail packaging and billing systems reflect this mandated ceiling rate for consumers. Price caps on essential pharmaceutical formulations are established to prevent overpricing and ensure affordable access to common medications across the country.

Under the regulatory framework, manufacturers and distributors must adhere strictly to notified rates, replacing older pricing structures with the newly prescribed ceiling limits. This mechanism protects retail buyers from exorbitant costs on necessary medical treatments and topical applications. Tax professionals and pharmacy operators should audit their existing inventory valuation and billing records to verify alignment with the newly mandated per-gram limit.

Compliance teams must track any future pricing notifications issued by the regulatory authority for related formulations to maintain proper legal standing. Bottom line: Verify your pharmacy billing software immediately to ensure compliance with the Rs 6.25 per gram price cap.